Antiatherosclerotic Effects of the Novel Angiotensin Receptor Antagonist Fimasartan on Plaque Progression and Stability in a Rabbit Model: A Double-Blind Placebo-Controlled Trial

作者：Lee Jong Young; Lee Cheol Whan; Kim Won Jang; Ahn Jung Min; Park Duk Woo; Kang Soo Jin; Lee Seung Whan; Kim Young Hak; Son Woo Chan; Jung Sunyoung; Park Seong Wook; Park Seung Jung^*

来源：Journal of Cardiovascular Pharmacology, 2013, 62(2): 229-236.

DOI：10.1097/FJC.0b013e318297458b

• atherosclerosis
• angiotensin
• rabbit
• drug

Objectives: To evaluate the effect of the novel angiotensin receptor blocker Fimasartan on the development of atherosclerosis and plaque stabilization in an animal model. %26lt;br%26gt;Methods: Twenty-four rabbits received an aortic balloon injury from 30 cm to a level just above the aortic valve to the iliac bifurcation using 3 Fr Fogarty catheters on third day of the experiment, followed by a 1% cholesterol diet for 8 weeks. The rabbits were randomized to receive placebo or 3 or 6 mgkg(-1)d(-1) Fimasartan. The study was double blinded. The rabbits started receiving their medications 2 days before the aortic balloon injury and treatment continued. Atherosclerosis burden was determined by calculating the intima-media ratio of the infrarenal portion of the aorta because the bulk of the atherosclerotic burden was limited to the infrarenal region. The frequency of plaque disruption with thrombosis and the proportions of the plaques that were occupied by macrophages, smooth muscle cells, and collagen were determined. %26lt;br%26gt;Results: Relative to the placebo group, the Fimasartan-treated rabbits had less atherosclerosis [intima-media ratio (mean +/- SEM) of 1.14 +/- 0.21 vs. 1.51 +/- 0.26, P = 0.005], fewer disrupted plaques with thrombi (3 of 16 vs. 5 of 8, P = 0.047), lower proportion of macrophages (17.5% +/- 2.5% vs. 26% +/- 3.5%, P = 0.03), higher proportion of smooth muscle cells (43.5% +/- 8.3% vs. 11.9% +/- 2.1%, P = 0.001), and higher proportion of collagen (34.3% +/- 6.4% vs. 19.7% +/- 2.1%, P = 0.02). %26lt;br%26gt;Conclusions: These results show that the newly developed angiotensin receptor blocker, Fimasartan, attenuated atherosclerosis progression and reduced macrophage accumulation in the rabbit aortic plaques.

• 出版日期2013-8